Search

Author/Creator Lu, Li‐Chun

1. Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma. (31st August 2019)

Authors:
Shao, Yu‐Yun; Liu, Tsung‐Hao; Hsu, Chiun; Lu, Li‐Chun; Shen, Yin‐Chung; Lin, Zhong‐Zhe; Cheng, Ann‐Lii; Hsu, Chih‐Hung
Journal:
Liver international
Issue:
Volume 39:Number 11(2019)
Page Start:
2184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma. Issue 6 (4th December 2012)

Authors:
Lu, Li‐Chun; Shao, Yu‐Yun; Kuo, Raymond N. C.; Lin, Zhong‐Zhe; Yeh, Yi‐Chun; Shau, Wen‐Yi; Hsu, Chih‐Hung; Cheng, Ann‐Lii; Lai, Mei‐Shu
Journal:
Cancer
Issue:
Volume 119:Issue 6(2013)
Page Start:
1210
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting tumor‐infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma. Issue 9 (26th December 2017)

Authors:
Chang, Chun‐Jung; Yang, Yao‐Hsu; Chiu, Chiao‐Juno; Lu, Li‐Chun; Liao, Chien‐Chia; Liang, Cher‐Wei; Hsu, Chih‐Hung; Cheng, Ann‐Lii
Journal:
International journal of cancer
Issue:
Volume 142:Issue 9(2018)
Page Start:
1878
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗